Buy Cinnarizine pills 25 mg 50 pcs
  • Buy Cinnarizine pills 25 mg 50 pcs

Cinnarizine

Anzhero-Sudzhensky HFZ
10000 Items
2019-06-23
Dosage form
Brand & Manufacturer
Package Size
$12.67
Quantity
  • done All payments are SSL encrypted
  • done Full Refund if you haven't received your order
  • done International shipping to the USA, UK and Europe

Clinical Pharmacology

  • The drug blocks the passage of calcium ions through the cell membrane. This helps to reduce their presence in the depot.
  • The tool reduces tinnitus, reduces headache. This happens because the property of the medicine to improve the condition of the blood vessels helps normalize the cerebral circulation.
  • Arteriole smooth muscle tone decreases. Peripheral and coronary blood circulation is improved, tissues are supplied with blood more fully. Possible post-ischemic hyperemia.
  • Biogenic vasoconstrictor substances after taking the drug do not have an adequate response from the body, because cinnarizine is able to suppress them. The ability of cinnarizine to exhibit antihistamine activity in moderate amounts also works to improve blood circulation.
  • The ingredients of the drug have an effect on blood cells, reduce its viscosity. Erythrocytes under the influence of the means improve the condition of the membranes, increasing their elasticity. The drug helps the cells to survive in conditions of lack of oxygen.

Indications

The tool is prescribed for such diseases:

  • peripheral circulation is deteriorating and it manifests itself as:
    • Raynaud's disease
    • thromboangiitis obliterans,
    • intermittent claudication
    • diabetic angiopathy,
    • thrombophlebitis,
    • pregangrenous conditions
    • trophic disorders, including ulcers;
  • ischemic stroke,
  • senile dementia,
  • encephalopathy,
  • prevention of migraine attacks,
  • states after strokes
  • prevention of kinetoz,
  • head injuries,
  • vestibular disorders.

Composition

Active ingredient: 25 mg cinnarizine

Additional ingredients:

  • povidone,
  • lactose,
  • magnesium stearate,
  • wheat starch
  • silica.

Cinnarizine is marketed under different brands and generic names, and comes in different dosage forms:

Brand nameManufacturerCountryDosage form
Cinnarizine Anzhero-Sudzhensky HFZ Russia pills
Cinnarizine PFK Obnovlenie Russia pills
Cinnarizine Pharma AD Bulgaria pills
Stugeron Gedeon Richter Hungary pills
Cinnarizine Sopharma Bulgaria pills

No customer reviews for the moment.

Write your review

Write your review

Cinnarizine

Dosage and Administration

Inside
In case of acute illness, children from 3 to 6 years old are prescribed 1 tab. every 2 hours (no more than 6 times / day) until the onset of improvement, then - 1/2 tab. 3 times / day until complete recovery.
Children from 6 to 12 years old appoint 1 tab. every hour (no more than 7-8 times / day) until the onset of improvement, then - 1 tab. 2 times / day until complete recovery.
Adults and children over 12 are prescribed 1 tab. every hour (no more than 12 times / day) before the onset of improvement, then - 1-2 tab. 3 times / day until complete recovery.
In case of chronic diseases, children from 3 to 6 years old are prescribed in 1/2 tab. 3 times / day; children from 6 to 12 years old - 1 tab. 2 times / day; adults and children over 12 are prescribed 1 tab. 3 times / day to improve the condition.
The course of treatment for the prevention of recurrence in the chronic course of the disease - up to 2 months.
Zinnabsin pills should be taken 30 minutes before or 30 minutes after a meal, slowly dissolving in the mouth. Children from 3 to 5 years old are recommended to dissolve the tablet in a small amount of liquid or give it in a crushed form under the tongue.

Adverse reactions

Possible: allergic reactions; in rare cases - skin reactions, with the development of which the drug should be canceled.
After the use of the drug, salivation may be observed (in this case, reduce the dose or stop taking the drug).

- Hypersensitivity to the drug.

It is not recommended to prescribe the drug to children under the age of 3 years due to the lack of clinical data.

Drug interactions

Drug interaction of the drug Zinnabsin with other drugs is not installed.

Pregnancy and Lactation

Use of the drug Cinnabsin during pregnancy and lactation (breastfeeding) is possible only if the intended benefits to the mother outweigh the potential risk to the fetus and child.

Special instructions

With the use of Zinnabsin may be a temporary deterioration. In this case, the patient should stop taking the drug and consult a doctor.
When using Zinnabsin, the use of other drugs is allowed.
The patient should be informed that in the absence of a therapeutic effect within 3 days the drug should be withdrawn and consult a doctor.
Taking Cinnabsin may have a negative effect on patients with celiac disease and lactose intolerance.

Overdosage

Currently, cases of drug overdose Zinnabsin were reported.

  • Brand name: Cinnabsin
  • Active ingredient: Homeopathic composition
  • Dosage form: Homeopathic lozenges.
  • Manufacturer: German Homeopathic Union
  • Country of Origin: Germany

Studies and clinical trials of Cinnarizine (Click to expand)

  1. Cinnarizine-induced parkinsonism: Ten years later
  2. Comparison of the effects of vinpocetine, vincamine, phenytoin, and cinnarizine in a rat model of cerebral ischemia
  3. The effects of single and repeated doses of oral scopolamine, cinnarizine, and placebo upon psychological performance and physiological functioning
  4. Enhancement of bioavailability of cinnarizine from its β-cyclodextrin complex on oral administration with DL-phenylalanine as a competing agent
  5. Enhancement of bioavailability of cinnarizine from its β-cyclodextrin complex on oral administration with dl-phenylalanine as a competing agent
  6. Enhancement of the oral bioavailability of cinnarizine in oleic acid in beagle dogs
  7. Movement disorders and depression due to flunarizine and cinnarizine
  8. A long-term follow-up study of cinnarizine- and flunarizine-induced parkinsonism
  9. Cinnarizine-induced parkinsonism: Ten years later
  10. Potentiometric membrane sensors for the selective determination of cinnarizine in pharmaceutical preparations
  11. Synthesis and pharmacological study of new calcium antagonists, analogues of cinnarizine and flunarizine
  12. Formulation, stability and degradation kinetics of intravenous cinnarizine lipid emulsion
  13. Pharmacokinetics, tissue distribution and safety of cinnarizine delivered in lipid emulsion
  14. A microcalorimetric investigation of the binding of cinnarizine to cyclodextrins
  15. Flow-injection determination of cinnarizine using surfactant-enhanced permanganate chemiluminesence
  16. Method development and validation for the simultaneous determination of cinnarizine and co-formulated drugs in pharmaceutical preparations by capillary electrophoresis
  17. Determination of cinnarizine in plasma by high-performance liquid chromatography
  18. Determination of cinnarizine in plasma by high-performance liquid chromatography
  19. Sensitive gas chromatographic method for the determination of cinnarizine and flunarizine in biological samples
  20. LC and TLC determination of cinnarizine in pharmaceutical preparations and serum
  21. Simultaneous determination of domperidone maleate and cinnarizine in a binary mixture using derivative ratio spectrophotometry and classical least squares calibration
  22. Simultaneous determination of cinnarizine and domepiridone maleate from tablet dosage form by reverse phase ion pair high performance liquid chromatography
  23. Promethazine, scopolamine and cinnarizine: comparative time course of psychological performance effects

8 other products in the same category:

arrow_upward